Cover Conference-at-a-Glance Final Agenda Eighth Annual

First Page		Document Content
Date: 2016-08-16 03:53:14 Medicine Clinical medicine Immunology Biology Immune system Monoclonal antibodies Biotechnology Glycoproteins Antibody Cancer immunotherapy Bispecific monoclonal antibody Phage display		Cover Conference-at-a-Glance Final Agenda Eighth Annual Add to Reading List Source URL: www.giievent.jp Download Document from Source Website File Size: 1,71 MB Share Document on Facebook

	# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,,#, Stephen M. Shaw 1,, Kim Wi DocID: 1vdls - View Document
	Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx DocID: 1uTyz - View Document
	FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program DocID: 1tGAn - View Document
	Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab DocID: 1tBVB - View Document